Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Change in Receivables (2023 - 2026)

Cannabis Bioscience International Holdings' Change in Receivables history spans 4 years, with the latest figure at -$20545.0 for Q1 2026.

  • On a quarterly basis, Change in Receivables fell 83.78% to -$20545.0 in Q1 2026 year-over-year; TTM through Feb 2026 was $21540.0, a 249.56% increase, with the full-year FY2025 number at $9155.0, down 10.14% from a year prior.
  • Change in Receivables hit -$20545.0 in Q1 2026 for Cannabis Bioscience International Holdings, down from $12845.0 in the prior quarter.
  • Over the last five years, Change in Receivables for CBIH hit a ceiling of $26654.0 in Q2 2025 and a floor of -$28765.0 in Q1 2023.
  • Historically, Change in Receivables has averaged -$651.62 across 4 years, with a median of -$1763.0 in 2024.
  • The widest YoY moves for Change in Receivables: up 760.64% in 2025, down 534.09% in 2025.
  • Tracing CBIH's Change in Receivables over 4 years: stood at -$8590.0 in 2023, then surged by 60.92% to -$3357.0 in 2024, then skyrocketed by 482.63% to $12845.0 in 2025, then crashed by 259.95% to -$20545.0 in 2026.
  • Business Quant data shows Change in Receivables for CBIH at -$20545.0 in Q1 2026, $12845.0 in Q4 2025, and $2586.0 in Q3 2025.